290 related articles for article (PubMed ID: 22143938)
1. DNA methylation biomarkers for lung cancer.
Rauch TA; Wang Z; Wu X; Kernstine KH; Riggs AD; Pfeifer GP
Tumour Biol; 2012 Apr; 33(2):287-96. PubMed ID: 22143938
[TBL] [Abstract][Full Text] [Related]
2. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.
Rauch TA; Zhong X; Wu X; Wang M; Kernstine KH; Wang Z; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):252-7. PubMed ID: 18162535
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
[TBL] [Abstract][Full Text] [Related]
4. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
6. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
7. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
9. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas.
Shiraishi M; Sekiguchi A; Oates AJ; Terry MJ; Miyamoto Y
Oncogene; 2002 May; 21(22):3659-62. PubMed ID: 12032868
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of tissue-specific differentially methylated genes with differential gene expression in non-small cell lung cancer].
Yin LG; Zou ZQ; Zhao HY; Zhang CL; Shen JG; Qi L; Qi M; Xue ZQ
Mol Biol (Mosk); 2014; 48(5):797-804. PubMed ID: 25842865
[TBL] [Abstract][Full Text] [Related]
11. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.
Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS
Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.
Shiraishi M; Sekiguchi A; Terry MJ; Oates AJ; Miyamoto Y; Chuu YH; Munakata M; Sekiya T
Oncogene; 2002 May; 21(23):3804-13. PubMed ID: 12032849
[TBL] [Abstract][Full Text] [Related]
14. CpG island hypermethylation in human astrocytomas.
Wu X; Rauch TA; Zhong X; Bennett WP; Latif F; Krex D; Pfeifer GP
Cancer Res; 2010 Apr; 70(7):2718-27. PubMed ID: 20233874
[TBL] [Abstract][Full Text] [Related]
15. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
McCabe MT; Lee EK; Vertino PM
Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
[TBL] [Abstract][Full Text] [Related]
16. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
18. Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis.
Shiraishi M; Chuu YH; Sekiya T
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2913-8. PubMed ID: 10077611
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns in lung carcinomas.
Pfeifer GP; Rauch TA
Semin Cancer Biol; 2009 Jun; 19(3):181-7. PubMed ID: 19429482
[TBL] [Abstract][Full Text] [Related]
20. Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.
Sun W; Iijima T; Kano J; Kobayashi H; Li D; Morishita Y; Okubo C; Anami Y; Noguchi M
Cancer Sci; 2008 Nov; 99(11):2177-84. PubMed ID: 18823374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
